Erick DeVinney - Dec 27, 2022 Form 4 Insider Report for Axogen, Inc. (AXGN)

Role
VP Peripheral Nerve Science
Signature
/s/Erick DeVinney
Stock symbol
AXGN
Transactions as of
Dec 27, 2022
Transactions value $
-$1
Form type
4
Date filed
12/28/2022, 08:34 PM
Previous filing
Jul 20, 2022
Next filing
Mar 20, 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXGN Common Stock Options Exercise $102K +20K +20.67% $5.09 117K Dec 27, 2022 Direct F1
transaction AXGN Common Stock Tax liability -$102K -10.8K -9.24% $9.44 106K Dec 27, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXGN Employee Stock Option (right to buy) Options Exercise $0 -20K -100% $0.00* 0 Dec 27, 2022 Common Stock 20K $5.09 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form is being filed to report the exercise of a stock option for a total of 20,000 shares by means of a stock swap. A stock swap is a method of exercising a stock option in which the option holder pays the exercise price using shares of stock already owned. As a result of this stock, the Reporting Person, on a net basis, acquired ownership of an additional 9,216 shares of common stock.